MedTrace Logo

Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication

NCT06037122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 558

Last updated 2023-09-14

No results posted yet for this study

Summary

The primary objective of this retrospective study was to assess the efficacy and safety of a bismuth quadruple regimen of a low-dose potassium-competitive acid blocker versus a standard-dose potassium-competitive acid blocker and a standard-dose proton pump inhibitor combined with amoxicillin and clarithromycin as the initial treatment of Helicobacter pylori infection.

Conditions

  • Helicobacter Pylori Infection

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Qin DU · Second Affiliated Hospital of Zhejiang University, School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-06-30
Completion
2024-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06037122 on ClinicalTrials.gov